BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 263297)

  • 1. Assessment of acute and chronic changes in parathyroid hormone secretion by a radioimmunoassay with predominant specificity for the carboxy-terminal region of the molecule.
    Parthemore JG; Roos BA; Parker DC; Kripke DF; Avioli LV; Deftos LJ
    J Clin Endocrinol Metab; 1978 Aug; 47(2):284-9. PubMed ID: 263297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.
    Lambert PW; Heath H; Sizemore GW
    J Clin Invest; 1979 Apr; 63(4):602-8. PubMed ID: 438324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of parathyroid hormone in patients with medullary thyroid carcinoma.
    Deftos LJ; Parthemore JG
    J Clin Invest; 1974 Aug; 54(2):416-20. PubMed ID: 4847251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
    Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for human parathyroid hormone for differentiation between patients with hypoparathyroidism, hyperparathyroidism and normals.
    Streibl W; Minne H; Raue F; Ziegler R
    Horm Metab Res; 1979 May; 11(5):375-6. PubMed ID: 478433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
    el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin secretion in primary hyperparathyroidism.
    Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1979 Aug; 49(2):223-6. PubMed ID: 457842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
    Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
    Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of parathyroid hormone.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
    Hackeng WH; Lips P; Netelenbos JC; Lips CJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassays for the detection of parathyroid hormone.
    Jüppner H; Potts JT
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a mid-region specific assay for human parathyroid hormone.
    Gleed JH; Hendy GN; Nussbaum SR; Rosenblatt M; O'Riordan JL
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):365-73. PubMed ID: 3742832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
    Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy.
    Tabolli S; Valtorta C; Bigi F; Minisola S; Mazzuoli GF
    Horm Res; 1986; 23(3):142-6. PubMed ID: 3949287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy.
    Goltzman D; Gomolin H; DeLean A; Wexler M; Meakins JL
    J Clin Endocrinol Metab; 1984 Jan; 58(1):70-5. PubMed ID: 6358244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism.
    Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
    Exp Clin Endocrinol; 1987 Dec; 90(3):324-30. PubMed ID: 3450531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism.
    Gautvik KM; Teig V; Halvorsen JF; Arnesen E; Myhre L; Heimann P; Tollman R
    Scand J Clin Lab Invest; 1979 Sep; 39(5):469-78. PubMed ID: 574982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone: radioimmunoassay and clinical interpretation.
    Hawker CD
    Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro.
    Birnbaumer ME; Schneider AB; Palmer D; Hanley DA; Sherwood LM
    J Clin Endocrinol Metab; 1977 Jul; 45(1):105-13. PubMed ID: 874057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.